Header cover image

German Pharmaceuticals & Biotech Potential Opportunities

Companies that are potentially undervalued based on future cash flows and market ratios.

3 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
DMPDermapharm Holding€54.00-4.4%-25.7%€2.9b€95.50PE13.9xE-4.2%4.0%
EVTEvotec€23.28-9.2%-32.8%€4.1b€41.14PE19.1xE-12.0%n/a
GXIGerresheimer€66.50-7.1%-25.7%€2.1b€95.43PE24.5xE19.6%1.9%
Page 1 of 1